nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—PPARG—nephron—focal segmental glomerulosclerosis	0.0469	0.256	CbGeAlD
Mesalazine—Lung fibrosis interstitial—Cyclosporine—focal segmental glomerulosclerosis	0.0388	0.0675	CcSEcCtD
Mesalazine—MPO—endothelium—focal segmental glomerulosclerosis	0.0249	0.136	CbGeAlD
Mesalazine—PTGS2—nephron—focal segmental glomerulosclerosis	0.024	0.131	CbGeAlD
Mesalazine—PPARG—endothelium—focal segmental glomerulosclerosis	0.0221	0.121	CbGeAlD
Mesalazine—Rheumatoid arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.0148	0.0258	CcSEcCtD
Mesalazine—Nephrotoxicity—Cyclosporine—focal segmental glomerulosclerosis	0.0141	0.0245	CcSEcCtD
Mesalazine—IKBKB—cortex of kidney—focal segmental glomerulosclerosis	0.0139	0.076	CbGeAlD
Mesalazine—Eye swelling—Cyclosporine—focal segmental glomerulosclerosis	0.0137	0.0239	CcSEcCtD
Mesalazine—PTGS1—endothelium—focal segmental glomerulosclerosis	0.0118	0.0645	CbGeAlD
Mesalazine—Stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.0118	0.0205	CcSEcCtD
Mesalazine—PTGS2—endothelium—focal segmental glomerulosclerosis	0.0113	0.0617	CbGeAlD
Mesalazine—MPO—kidney—focal segmental glomerulosclerosis	0.01	0.0547	CbGeAlD
Mesalazine—PPARG—Adipogenesis—ZMPSTE24—focal segmental glomerulosclerosis	0.00982	0.0409	CbGpPWpGaD
Mesalazine—Pancreatitis acute—Cyclosporine—focal segmental glomerulosclerosis	0.00968	0.0169	CcSEcCtD
Mesalazine—PTGS1—Overview of nanoparticle effects—COL4A1—focal segmental glomerulosclerosis	0.00948	0.0395	CbGpPWpGaD
Mesalazine—Nephropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00939	0.0163	CcSEcCtD
Mesalazine—PPARG—kidney—focal segmental glomerulosclerosis	0.0089	0.0486	CbGeAlD
Mesalazine—Ear disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00828	0.0144	CcSEcCtD
Mesalazine—Urine abnormality—Cyclosporine—focal segmental glomerulosclerosis	0.00807	0.0141	CcSEcCtD
Mesalazine—Micturition urgency—Cyclosporine—focal segmental glomerulosclerosis	0.00788	0.0137	CcSEcCtD
Mesalazine—Nephropathy toxic—Cyclosporine—focal segmental glomerulosclerosis	0.00778	0.0135	CcSEcCtD
Mesalazine—Hirsutism—Cyclosporine—focal segmental glomerulosclerosis	0.00769	0.0134	CcSEcCtD
Mesalazine—Urine analysis abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.0076	0.0132	CcSEcCtD
Mesalazine—Gastrointestinal symptom NOS—Cyclosporine—focal segmental glomerulosclerosis	0.0076	0.0132	CcSEcCtD
Mesalazine—PTGS2—Overview of nanoparticle effects—COL4A1—focal segmental glomerulosclerosis	0.00752	0.0314	CbGpPWpGaD
Mesalazine—Psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.00711	0.0124	CcSEcCtD
Mesalazine—CHUK—Interleukin-11 Signaling Pathway—PIAS1—focal segmental glomerulosclerosis	0.00706	0.0294	CbGpPWpGaD
Mesalazine—Hypomagnesaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00704	0.0122	CcSEcCtD
Mesalazine—Nail disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00689	0.012	CcSEcCtD
Mesalazine—Burning sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00643	0.0112	CcSEcCtD
Mesalazine—IKBKB—Interleukin-11 Signaling Pathway—PIAS1—focal segmental glomerulosclerosis	0.0064	0.0267	CbGpPWpGaD
Mesalazine—CHUK—Osteopontin Signaling—SPP1—focal segmental glomerulosclerosis	0.00637	0.0265	CbGpPWpGaD
Mesalazine—Interstitial lung disease—Cyclosporine—focal segmental glomerulosclerosis	0.00632	0.011	CcSEcCtD
Mesalazine—Thrombosis—Cyclosporine—focal segmental glomerulosclerosis	0.00632	0.011	CcSEcCtD
Mesalazine—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00615	0.0107	CcSEcCtD
Mesalazine—Cholestasis—Cyclosporine—focal segmental glomerulosclerosis	0.00589	0.0102	CcSEcCtD
Mesalazine—Hepatotoxicity—Cyclosporine—focal segmental glomerulosclerosis	0.00579	0.0101	CcSEcCtD
Mesalazine—IKBKB—Osteopontin Signaling—SPP1—focal segmental glomerulosclerosis	0.00577	0.0241	CbGpPWpGaD
Mesalazine—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.00569	0.00991	CcSEcCtD
Mesalazine—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00569	0.00991	CcSEcCtD
Mesalazine—Liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.00531	0.00925	CcSEcCtD
Mesalazine—Acne—Cyclosporine—focal segmental glomerulosclerosis	0.00531	0.00925	CcSEcCtD
Mesalazine—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00512	0.00892	CcSEcCtD
Mesalazine—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00509	0.00886	CcSEcCtD
Mesalazine—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00498	0.00867	CcSEcCtD
Mesalazine—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00495	0.00861	CcSEcCtD
Mesalazine—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00492	0.00856	CcSEcCtD
Mesalazine—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00492	0.00856	CcSEcCtD
Mesalazine—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00479	0.00833	CcSEcCtD
Mesalazine—PTGS1—kidney—focal segmental glomerulosclerosis	0.00476	0.026	CbGeAlD
Mesalazine—PTGS2—kidney—focal segmental glomerulosclerosis	0.00455	0.0248	CbGeAlD
Mesalazine—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.00447	0.00778	CcSEcCtD
Mesalazine—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00439	0.00764	CcSEcCtD
Mesalazine—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.00434	0.00756	CcSEcCtD
Mesalazine—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00427	0.00743	CcSEcCtD
Mesalazine—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.00422	0.00735	CcSEcCtD
Mesalazine—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.0042	0.00731	CcSEcCtD
Mesalazine—MPO—IL23-mediated signaling events—NOS2—focal segmental glomerulosclerosis	0.00415	0.0173	CbGpPWpGaD
Mesalazine—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00411	0.00715	CcSEcCtD
Mesalazine—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00408	0.00711	CcSEcCtD
Mesalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—ANGPT2—focal segmental glomerulosclerosis	0.00402	0.0168	CbGpPWpGaD
Mesalazine—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0038	0.00662	CcSEcCtD
Mesalazine—CHUK—Hair Follicle Development: Induction (Part 1 of 3)—CTGF—focal segmental glomerulosclerosis	0.0038	0.0158	CbGpPWpGaD
Mesalazine—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00366	0.00637	CcSEcCtD
Mesalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—ANGPT2—focal segmental glomerulosclerosis	0.00364	0.0152	CbGpPWpGaD
Mesalazine—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00363	0.00631	CcSEcCtD
Mesalazine—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00363	0.00631	CcSEcCtD
Mesalazine—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00361	0.00629	CcSEcCtD
Mesalazine—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00361	0.00629	CcSEcCtD
Mesalazine—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00359	0.00626	CcSEcCtD
Mesalazine—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.0035	0.00609	CcSEcCtD
Mesalazine—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00345	0.00601	CcSEcCtD
Mesalazine—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—CTGF—focal segmental glomerulosclerosis	0.00344	0.0143	CbGpPWpGaD
Mesalazine—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00341	0.00593	CcSEcCtD
Mesalazine—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00339	0.00591	CcSEcCtD
Mesalazine—CHUK—Osteopontin Signaling—MMP9—focal segmental glomerulosclerosis	0.00339	0.0141	CbGpPWpGaD
Mesalazine—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00334	0.00581	CcSEcCtD
Mesalazine—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00331	0.00576	CcSEcCtD
Mesalazine—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00324	0.00565	CcSEcCtD
Mesalazine—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00322	0.0056	CcSEcCtD
Mesalazine—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00319	0.00556	CcSEcCtD
Mesalazine—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00319	0.00556	CcSEcCtD
Mesalazine—CHUK—Osteopontin-mediated events—SPP1—focal segmental glomerulosclerosis	0.00318	0.0132	CbGpPWpGaD
Mesalazine—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00307	0.00535	CcSEcCtD
Mesalazine—IKBKB—Osteopontin Signaling—MMP9—focal segmental glomerulosclerosis	0.00307	0.0128	CbGpPWpGaD
Mesalazine—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00304	0.00529	CcSEcCtD
Mesalazine—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00297	0.00518	CcSEcCtD
Mesalazine—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00296	0.00516	CcSEcCtD
Mesalazine—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00293	0.0051	CcSEcCtD
Mesalazine—PTGS1—Overview of nanoparticle effects—FN1—focal segmental glomerulosclerosis	0.00293	0.0122	CbGpPWpGaD
Mesalazine—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00292	0.00509	CcSEcCtD
Mesalazine—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00287	0.005	CcSEcCtD
Mesalazine—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00282	0.00491	CcSEcCtD
Mesalazine—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.0028	0.00488	CcSEcCtD
Mesalazine—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00276	0.0048	CcSEcCtD
Mesalazine—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00275	0.00479	CcSEcCtD
Mesalazine—MPO—Vitamin B12 Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.0027	0.0113	CbGpPWpGaD
Mesalazine—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.0027	0.00469	CcSEcCtD
Mesalazine—MPO—Vitamin B12 Metabolism—ALB—focal segmental glomerulosclerosis	0.0027	0.0112	CbGpPWpGaD
Mesalazine—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00269	0.00468	CcSEcCtD
Mesalazine—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.00265	0.011	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.00263	0.011	CbGpPWpGaD
Mesalazine—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00262	0.00456	CcSEcCtD
Mesalazine—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00261	0.00454	CcSEcCtD
Mesalazine—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00259	0.00451	CcSEcCtD
Mesalazine—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00255	0.00444	CcSEcCtD
Mesalazine—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.00442	CcSEcCtD
Mesalazine—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00251	0.00438	CcSEcCtD
Mesalazine—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.0025	0.00435	CcSEcCtD
Mesalazine—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.0025	0.00435	CcSEcCtD
Mesalazine—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00249	0.00434	CcSEcCtD
Mesalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—focal segmental glomerulosclerosis	0.00248	0.0104	CbGpPWpGaD
Mesalazine—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00246	0.00428	CcSEcCtD
Mesalazine—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.00427	CcSEcCtD
Mesalazine—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00244	0.00424	CcSEcCtD
Mesalazine—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00244	0.00424	CcSEcCtD
Mesalazine—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00243	0.00423	CcSEcCtD
Mesalazine—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00243	0.00423	CcSEcCtD
Mesalazine—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00238	0.00415	CcSEcCtD
Mesalazine—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00236	0.00412	CcSEcCtD
Mesalazine—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00236	0.00411	CcSEcCtD
Mesalazine—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00235	0.00408	CcSEcCtD
Mesalazine—PTGS2—Overview of nanoparticle effects—FN1—focal segmental glomerulosclerosis	0.00232	0.00969	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—COL4A4—focal segmental glomerulosclerosis	0.00227	0.00945	CbGpPWpGaD
Mesalazine—CHUK—BCR signaling pathway—CD79A—focal segmental glomerulosclerosis	0.00226	0.00943	CbGpPWpGaD
Mesalazine—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00226	0.00393	CcSEcCtD
Mesalazine—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.00392	CcSEcCtD
Mesalazine—CHUK—Osteopontin-mediated events—MMP2—focal segmental glomerulosclerosis	0.00225	0.00938	CbGpPWpGaD
Mesalazine—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00224	0.00391	CcSEcCtD
Mesalazine—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00224	0.00391	CcSEcCtD
Mesalazine—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.00388	CcSEcCtD
Mesalazine—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.00386	CcSEcCtD
Mesalazine—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00221	0.00384	CcSEcCtD
Mesalazine—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0022	0.00383	CcSEcCtD
Mesalazine—MPO—Folate Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.0022	0.00916	CbGpPWpGaD
Mesalazine—MPO—Folate Metabolism—ALB—focal segmental glomerulosclerosis	0.00219	0.00915	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.00218	0.00909	CbGpPWpGaD
Mesalazine—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—focal segmental glomerulosclerosis	0.00214	0.0089	CbGpPWpGaD
Mesalazine—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.0021	0.00877	CbGpPWpGaD
Mesalazine—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00209	0.00364	CcSEcCtD
Mesalazine—CHUK—Signaling by PDGF—COL4A1—focal segmental glomerulosclerosis	0.00208	0.00869	CbGpPWpGaD
Mesalazine—IKBKB—BCR signaling pathway—CD79A—focal segmental glomerulosclerosis	0.00205	0.00856	CbGpPWpGaD
Mesalazine—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00204	0.00355	CcSEcCtD
Mesalazine—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00202	0.00352	CcSEcCtD
Mesalazine—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00201	0.00351	CcSEcCtD
Mesalazine—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.00345	CcSEcCtD
Mesalazine—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00197	0.00342	CcSEcCtD
Mesalazine—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00193	0.00335	CcSEcCtD
Mesalazine—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00192	0.00334	CcSEcCtD
Mesalazine—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00191	0.00333	CcSEcCtD
Mesalazine—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.0019	0.0033	CcSEcCtD
Mesalazine—PPARG—SREBP signalling—LPL—focal segmental glomerulosclerosis	0.00188	0.00785	CbGpPWpGaD
Mesalazine—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00188	0.00327	CcSEcCtD
Mesalazine—PPARG—PPARA activates gene expression—CTGF—focal segmental glomerulosclerosis	0.00187	0.0078	CbGpPWpGaD
Mesalazine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00184	0.00321	CcSEcCtD
Mesalazine—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—focal segmental glomerulosclerosis	0.00183	0.00764	CbGpPWpGaD
Mesalazine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00183	0.00319	CcSEcCtD
Mesalazine—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.00316	CcSEcCtD
Mesalazine—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.00314	CcSEcCtD
Mesalazine—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00179	0.00311	CcSEcCtD
Mesalazine—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.00307	CcSEcCtD
Mesalazine—CHUK—Signaling by PDGF—COL4A3—focal segmental glomerulosclerosis	0.00176	0.00734	CbGpPWpGaD
Mesalazine—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.00306	CcSEcCtD
Mesalazine—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00175	0.00304	CcSEcCtD
Mesalazine—CHUK—Validated nuclear estrogen receptor alpha network—PCNA—focal segmental glomerulosclerosis	0.00175	0.00728	CbGpPWpGaD
Mesalazine—MPO—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.00175	0.00728	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—COL4A1—focal segmental glomerulosclerosis	0.00175	0.00728	CbGpPWpGaD
Mesalazine—MPO—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.00174	0.00727	CbGpPWpGaD
Mesalazine—PPARG—Transcriptional regulation of white adipocyte differentiation—LPL—focal segmental glomerulosclerosis	0.00173	0.00719	CbGpPWpGaD
Mesalazine—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—focal segmental glomerulosclerosis	0.00171	0.00712	CbGpPWpGaD
Mesalazine—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.00297	CcSEcCtD
Mesalazine—CHUK—Osteopontin-mediated events—MMP9—focal segmental glomerulosclerosis	0.00169	0.00705	CbGpPWpGaD
Mesalazine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00169	0.00294	CcSEcCtD
Mesalazine—CHUK—B Cell Receptor Signaling Pathway—CD79A—focal segmental glomerulosclerosis	0.00168	0.00702	CbGpPWpGaD
Mesalazine—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.0029	CcSEcCtD
Mesalazine—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.0029	CcSEcCtD
Mesalazine—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.0029	CcSEcCtD
Mesalazine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.00289	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.00288	CcSEcCtD
Mesalazine—ALOX5—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.00165	0.00687	CbGpPWpGaD
Mesalazine—ALOX5—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.00164	0.00686	CbGpPWpGaD
Mesalazine—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.00286	CcSEcCtD
Mesalazine—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.00283	CcSEcCtD
Mesalazine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.0028	CcSEcCtD
Mesalazine—CHUK—Cytokine Signaling in Immune system—PIAS1—focal segmental glomerulosclerosis	0.00161	0.0067	CbGpPWpGaD
Mesalazine—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.00278	CcSEcCtD
Mesalazine—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.00278	CcSEcCtD
Mesalazine—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.00276	CcSEcCtD
Mesalazine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.00272	CcSEcCtD
Mesalazine—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.00272	CcSEcCtD
Mesalazine—Diflunisal—ALB—focal segmental glomerulosclerosis	0.00156	0.642	CrCbGaD
Mesalazine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—EDN1—focal segmental glomerulosclerosis	0.00156	0.00649	CbGpPWpGaD
Mesalazine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.0027	CcSEcCtD
Mesalazine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.00268	CcSEcCtD
Mesalazine—IKBKB—B Cell Receptor Signaling Pathway—CD79A—focal segmental glomerulosclerosis	0.00153	0.00636	CbGpPWpGaD
Mesalazine—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00152	0.00265	CcSEcCtD
Mesalazine—PPARG—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.00147	0.00612	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—PIAS1—focal segmental glomerulosclerosis	0.00146	0.00607	CbGpPWpGaD
Mesalazine—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.00253	CcSEcCtD
Mesalazine—PTGS2—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	0.00145	0.00604	CbGpPWpGaD
Mesalazine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00251	CcSEcCtD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.00144	0.006	CbGpPWpGaD
Mesalazine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.00249	CcSEcCtD
Mesalazine—CHUK—AGE/RAGE pathway—NOS2—focal segmental glomerulosclerosis	0.00143	0.00597	CbGpPWpGaD
Mesalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—FN1—focal segmental glomerulosclerosis	0.00143	0.00597	CbGpPWpGaD
Mesalazine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00247	CcSEcCtD
Mesalazine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00247	CcSEcCtD
Mesalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—NOS2—focal segmental glomerulosclerosis	0.00141	0.0059	CbGpPWpGaD
Mesalazine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—EDN1—focal segmental glomerulosclerosis	0.00141	0.00589	CbGpPWpGaD
Mesalazine—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—focal segmental glomerulosclerosis	0.00141	0.00587	CbGpPWpGaD
Mesalazine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.00244	CcSEcCtD
Mesalazine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00241	CcSEcCtD
Mesalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—focal segmental glomerulosclerosis	0.00138	0.00576	CbGpPWpGaD
Mesalazine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.0024	CcSEcCtD
Mesalazine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.00239	CcSEcCtD
Mesalazine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.00237	CcSEcCtD
Mesalazine—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.00237	CcSEcCtD
Mesalazine—CHUK—TWEAK Signaling Pathway—MMP9—focal segmental glomerulosclerosis	0.00133	0.00553	CbGpPWpGaD
Mesalazine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.00229	CcSEcCtD
Mesalazine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.00227	CcSEcCtD
Mesalazine—IKBKB—AGE/RAGE pathway—NOS2—focal segmental glomerulosclerosis	0.0013	0.00541	CbGpPWpGaD
Mesalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—FN1—focal segmental glomerulosclerosis	0.0013	0.00541	CbGpPWpGaD
Mesalazine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—AGT—focal segmental glomerulosclerosis	0.00129	0.00539	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.00129	0.00539	CbGpPWpGaD
Mesalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—NOS2—focal segmental glomerulosclerosis	0.00128	0.00535	CbGpPWpGaD
Mesalazine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.00221	CcSEcCtD
Mesalazine—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	0.00126	0.00526	CbGpPWpGaD
Mesalazine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.00219	CcSEcCtD
Mesalazine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.00219	CcSEcCtD
Mesalazine—CHUK—AGE/RAGE pathway—MMP2—focal segmental glomerulosclerosis	0.00123	0.00512	CbGpPWpGaD
Mesalazine—CHUK—Toll-like Receptor Signaling Pathway—SPP1—focal segmental glomerulosclerosis	0.00123	0.00511	CbGpPWpGaD
Mesalazine—IKBKB—TWEAK Signaling Pathway—MMP9—focal segmental glomerulosclerosis	0.0012	0.00501	CbGpPWpGaD
Mesalazine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.00205	CcSEcCtD
Mesalazine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—AGT—focal segmental glomerulosclerosis	0.00117	0.00489	CbGpPWpGaD
Mesalazine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00199	CcSEcCtD
Mesalazine—PPARG—Adipogenesis—LPL—focal segmental glomerulosclerosis	0.00114	0.00473	CbGpPWpGaD
Mesalazine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.00196	CcSEcCtD
Mesalazine—IKBKB—AGE/RAGE pathway—MMP2—focal segmental glomerulosclerosis	0.00111	0.00464	CbGpPWpGaD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—SPP1—focal segmental glomerulosclerosis	0.00111	0.00463	CbGpPWpGaD
Mesalazine—PPARG—PPARA activates gene expression—AGT—focal segmental glomerulosclerosis	0.00111	0.00463	CbGpPWpGaD
Mesalazine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.0019	CcSEcCtD
Mesalazine—PPARG—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.00109	0.00453	CbGpPWpGaD
Mesalazine—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—focal segmental glomerulosclerosis	0.00109	0.00453	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—GNAQ—focal segmental glomerulosclerosis	0.00106	0.00444	CbGpPWpGaD
Mesalazine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00184	CcSEcCtD
Mesalazine—CHUK—Interleukin-11 Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.00105	0.00439	CbGpPWpGaD
Mesalazine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00177	CcSEcCtD
Mesalazine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00175	CcSEcCtD
Mesalazine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.001	0.00175	CcSEcCtD
Mesalazine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000999	0.00174	CcSEcCtD
Mesalazine—PPARG—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.000998	0.00416	CbGpPWpGaD
Mesalazine—PPARG—Adipogenesis—AGT—focal segmental glomerulosclerosis	0.000971	0.00405	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—CD79A—focal segmental glomerulosclerosis	0.000963	0.00401	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—SPP1—focal segmental glomerulosclerosis	0.000957	0.00399	CbGpPWpGaD
Mesalazine—IKBKB—Interleukin-11 Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.000955	0.00398	CbGpPWpGaD
Mesalazine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000947	0.00165	CcSEcCtD
Mesalazine—CHUK—BDNF signaling pathway—SPP1—focal segmental glomerulosclerosis	0.00093	0.00388	CbGpPWpGaD
Mesalazine—CHUK—AGE/RAGE pathway—MMP9—focal segmental glomerulosclerosis	0.000923	0.00385	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000922	0.00385	CbGpPWpGaD
Mesalazine—CHUK—Cardiac Hypertrophic Response—TGFB1—focal segmental glomerulosclerosis	0.000881	0.00367	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—CD79A—focal segmental glomerulosclerosis	0.000873	0.00364	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—SPP1—focal segmental glomerulosclerosis	0.000867	0.00362	CbGpPWpGaD
Mesalazine—Salicylic acid—ALB—focal segmental glomerulosclerosis	0.000867	0.357	CrCbGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000853	0.00356	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.000844	0.00352	CbGpPWpGaD
Mesalazine—IKBKB—BDNF signaling pathway—SPP1—focal segmental glomerulosclerosis	0.000843	0.00352	CbGpPWpGaD
Mesalazine—IKBKB—AGE/RAGE pathway—MMP9—focal segmental glomerulosclerosis	0.000837	0.00349	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000812	0.00339	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.000805	0.00335	CbGpPWpGaD
Mesalazine—IKBKB—Cardiac Hypertrophic Response—TGFB1—focal segmental glomerulosclerosis	0.000798	0.00333	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—SPP1—focal segmental glomerulosclerosis	0.000771	0.00321	CbGpPWpGaD
Mesalazine—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	0.000748	0.00312	CbGpPWpGaD
Mesalazine—PPARG—Adipogenesis—SERPINE1—focal segmental glomerulosclerosis	0.000747	0.00311	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000728	0.00304	CbGpPWpGaD
Mesalazine—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—focal segmental glomerulosclerosis	0.000717	0.00299	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.000715	0.00298	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.000713	0.00297	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—MYH9—focal segmental glomerulosclerosis	0.000667	0.00278	CbGpPWpGaD
Mesalazine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—focal segmental glomerulosclerosis	0.000628	0.00262	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	0.000626	0.00261	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.00062	0.00259	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—MYH9—focal segmental glomerulosclerosis	0.000605	0.00252	CbGpPWpGaD
Mesalazine—PPARG—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	0.000598	0.00249	CbGpPWpGaD
Mesalazine—CHUK—TCR Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.000594	0.00248	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000571	0.00238	CbGpPWpGaD
Mesalazine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—focal segmental glomerulosclerosis	0.000569	0.00237	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.000567	0.00237	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.000566	0.00236	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000563	0.00235	CbGpPWpGaD
Mesalazine—IKBKB—TCR Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.000538	0.00224	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	0.000533	0.00222	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	0.000527	0.0022	CbGpPWpGaD
Mesalazine—CHUK—Immune System—PIAS1—focal segmental glomerulosclerosis	0.000525	0.00219	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—MMP9—focal segmental glomerulosclerosis	0.000503	0.0021	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000503	0.0021	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000482	0.00201	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—PIAS1—focal segmental glomerulosclerosis	0.000476	0.00198	CbGpPWpGaD
Mesalazine—PPARG—Adipogenesis—TGFB1—focal segmental glomerulosclerosis	0.000471	0.00196	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000431	0.0018	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000411	0.00171	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.0004	0.00167	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.00039	0.00163	CbGpPWpGaD
Mesalazine—CHUK—Immune System—MYH9—focal segmental glomerulosclerosis	0.000389	0.00162	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	0.000388	0.00162	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.00037	0.00154	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000362	0.00151	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—MYH9—focal segmental glomerulosclerosis	0.000352	0.00147	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000352	0.00147	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	0.000352	0.00147	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000348	0.00145	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	0.000344	0.00143	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000339	0.00141	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000333	0.00139	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.000327	0.00136	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000325	0.00136	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000318	0.00132	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	0.000316	0.00132	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000312	0.0013	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000308	0.00128	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000298	0.00124	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—CTGF—focal segmental glomerulosclerosis	0.000288	0.0012	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	0.000287	0.0012	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	0.000283	0.00118	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000283	0.00118	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.00028	0.00117	CbGpPWpGaD
Mesalazine—PPARG—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	0.000273	0.00114	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000263	0.0011	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000262	0.00109	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000254	0.00106	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—LPL—focal segmental glomerulosclerosis	0.000251	0.00105	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000244	0.00102	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000239	0.000996	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD79A—focal segmental glomerulosclerosis	0.000235	0.000982	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000229	0.000954	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000224	0.000933	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—AGT—focal segmental glomerulosclerosis	0.000214	0.000894	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD79A—focal segmental glomerulosclerosis	0.000213	0.00089	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000209	0.00087	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000206	0.00086	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000197	0.000819	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000194	0.000808	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000194	0.000807	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000193	0.000803	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000193	0.000803	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD40LG—focal segmental glomerulosclerosis	0.000192	0.0008	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000178	0.000743	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000176	0.000732	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000175	0.000728	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD40LG—focal segmental glomerulosclerosis	0.000174	0.000726	CbGpPWpGaD
Mesalazine—CHUK—Disease—LPL—focal segmental glomerulosclerosis	0.000174	0.000725	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000166	0.000691	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—ALB—focal segmental glomerulosclerosis	0.000165	0.000686	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.000162	0.000675	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000162	0.000675	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.00016	0.000668	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000157	0.000654	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—LPL—focal segmental glomerulosclerosis	0.000155	0.000647	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000148	0.000617	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000147	0.000612	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000144	0.000602	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000141	0.000589	CbGpPWpGaD
Mesalazine—CHUK—Disease—NOS2—focal segmental glomerulosclerosis	0.000136	0.000566	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000134	0.00056	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—AGT—focal segmental glomerulosclerosis	0.000133	0.000553	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	0.000131	0.000547	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000127	0.00053	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000126	0.000523	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000124	0.000519	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000122	0.000508	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000115	0.000481	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000115	0.000478	CbGpPWpGaD
Mesalazine—CHUK—Disease—SERPINE1—focal segmental glomerulosclerosis	0.000114	0.000477	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000114	0.000475	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00011	0.00046	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—LPL—focal segmental glomerulosclerosis	0.000109	0.000453	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000105	0.000436	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000104	0.000434	CbGpPWpGaD
Mesalazine—PTGS2—Disease—LPL—focal segmental glomerulosclerosis	0.000103	0.00043	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ALB—focal segmental glomerulosclerosis	0.000102	0.000425	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—FN1—focal segmental glomerulosclerosis	9.63e-05	0.000401	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—AGT—focal segmental glomerulosclerosis	9.45e-05	0.000394	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—AGT—focal segmental glomerulosclerosis	9.3e-05	0.000388	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—FN1—focal segmental glomerulosclerosis	8.73e-05	0.000364	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—LPL—focal segmental glomerulosclerosis	8.63e-05	0.00036	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NOS2—focal segmental glomerulosclerosis	8.05e-05	0.000336	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	8.01e-05	0.000334	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—AGT—focal segmental glomerulosclerosis	7.38e-05	0.000308	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	7.26e-05	0.000303	CbGpPWpGaD
Mesalazine—CHUK—Disease—TGFB1—focal segmental glomerulosclerosis	7.22e-05	0.000301	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ALB—focal segmental glomerulosclerosis	7.14e-05	0.000297	CbGpPWpGaD
Mesalazine—PTGS2—Disease—SERPINE1—focal segmental glomerulosclerosis	6.78e-05	0.000283	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.14e-05	0.000256	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ALB—focal segmental glomerulosclerosis	5.66e-05	0.000236	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.56e-05	0.000232	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.06e-05	0.000211	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.59e-05	0.000191	CbGpPWpGaD
Mesalazine—PTGS2—Disease—TGFB1—focal segmental glomerulosclerosis	4.28e-05	0.000178	CbGpPWpGaD
